Pasithea Therapeutics (KTTA) Other Gross PP&E Adjustments (2021 - 2024)
Pasithea Therapeutics (KTTA) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $7155.0 as the latest value for Q3 2024.
- Quarterly Other Gross PP&E Adjustments rose 101.93% to $7155.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $7155.0 through Sep 2024, up 101.93% year-over-year, with the annual reading at -$344575.0 for FY2023, 11.05% up from the prior year.
- Other Gross PP&E Adjustments hit $7155.0 in Q3 2024 for Pasithea Therapeutics, up from -$150386.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $7155.0 in Q3 2024 to a low of -$184.2 million in Q1 2023.
- Historically, Other Gross PP&E Adjustments has averaged -$19.0 million across 4 years, with a median of -$387372.0 in 2022.
- Biggest five-year swings in Other Gross PP&E Adjustments: decreased 2.31% in 2023 and later surged 101.93% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at -$21.5 million in 2021, then soared by 98.2% to -$387372.0 in 2022, then rose by 11.05% to -$344575.0 in 2023, then skyrocketed by 102.08% to $7155.0 in 2024.
- Business Quant data shows Other Gross PP&E Adjustments for KTTA at $7155.0 in Q3 2024, -$150386.0 in Q2 2024, and -$339953.0 in Q1 2024.